Work

Figure S5 from Antibody–Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Antitumor Activity in Colorectal Cancer

Year: 2026

Type: other

Abstract: HPLC and deconvoluted ESI-MS analysis of DBCO-PEG3-EGCit-PABQ-Duocarmycin DM-gluc (purity >95%).

DOI: 10.1158/0008-5472.32704079

Authors: Joan Jacob, Yasuaki Anami, Peyton C. High, Zhengdong Liang, Shraddha Subramanian, Sukhen C. Ghosh, Solmaz AghaAmiri, Cara Guernsey-Biddle, Ha Tran, Julie Rowe, Ali Azhdarinia, Kyoji Tsuchikama, Kendra S. Carmon

Topic: Toxin Mechanisms and Immunotoxins

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7165012487

Cites:

Cited by:

Related to: